Lyra Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Lyra Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Lyra Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.12M, a 17% decline year-over-year.
  • Lyra Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $6.21M, a 3.89% decline year-over-year.
  • Lyra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.89M, a 8.08% increase from 2022.
  • Lyra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.45M, a 96.6% increase from 2021.
  • Lyra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.77M, a 52.8% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.89M +$440K +8.08% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 $5.45M +$2.68M +96.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $2.77M +$957K +52.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $1.81M +$1.57M +643% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 $244K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.